Bristol-Myers Squibb Co (BMY)
44.70
-4.16
(-8.51%)
USD |
NYSE |
Apr 25, 16:00
44.85
+0.15
(+0.34%)
Pre-Market: 05:13
Bristol-Myers Squibb Net Income (TTM): 8.025B for Dec. 31, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 8.025B |
| September 30, 2023 | 8.285B |
| June 30, 2023 | 7.963B |
| March 31, 2023 | 7.311B |
| December 31, 2022 | 6.327B |
| September 30, 2022 | 6.677B |
| June 30, 2022 | 6.617B |
| March 31, 2022 | 6.251B |
| December 31, 2021 | 6.994B |
| September 30, 2021 | -5.405B |
| June 30, 2021 | -5.079B |
| March 31, 2021 | -6.219B |
| December 31, 2020 | -9.015B |
| September 30, 2020 | -44.00M |
| June 30, 2020 | -563.00M |
| March 31, 2020 | 954.00M |
| December 31, 2019 | 3.439B |
| September 30, 2019 | 5.655B |
| June 30, 2019 | 6.203B |
| March 31, 2019 | 5.144B |
| December 31, 2018 | 4.92B |
| September 30, 2018 | 1.432B |
| June 30, 2018 | 376.00M |
| March 31, 2018 | 919.00M |
| December 31, 2017 | 1.007B |
| Date | Value |
|---|---|
| September 30, 2017 | 4.229B |
| June 30, 2017 | 4.586B |
| March 31, 2017 | 4.836B |
| December 31, 2016 | 4.457B |
| September 30, 2016 | 3.366B |
| June 30, 2016 | 2.87B |
| March 31, 2016 | 1.574B |
| December 31, 2015 | 1.565B |
| September 30, 2015 | 1.775B |
| June 30, 2015 | 1.79B |
| March 31, 2015 | 2.253B |
| December 31, 2014 | 2.004B |
| September 30, 2014 | 2.717B |
| June 30, 2014 | 2.688B |
| March 31, 2014 | 2.891B |
| December 31, 2013 | 2.563B |
| September 30, 2013 | 2.762B |
| June 30, 2013 | 1.359B |
| March 31, 2013 | 1.468B |
| December 31, 2012 | 1.96B |
| September 30, 2012 | 1.887B |
| June 30, 2012 | 3.567B |
| March 31, 2012 | 3.824B |
| December 31, 2011 | 3.709B |
| September 30, 2011 | 3.34B |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-9.015B
Minimum
Dec 2020
8.285B
Maximum
Sep 2023
2.862B
Average
6.203B
Median
Jun 2019
Net Income (TTM) Benchmarks
| Amgen Inc | 6.717B |
| Gilead Sciences Inc | 5.664B |
| Johnson & Johnson | 40.58B |
| Karuna Therapeutics Inc (DELISTED) | -433.68M |
| 2seventy bio Inc | -217.57M |